Civetta Therapeutics ceased business operations in December 2023 and entered an Assignment for the Benefit of Creditors (liquidation). The submission contains major red flags, including the fraudulent claim that 'most people have used my product' (impossible for a niche oncology biotech) and erroneous revenue data. The company is currently inactive with its IP up for sale, resulting in a near-zero utility score.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline